Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma.

MLA

Lassman, Andrew B., et al. “Epidermal Growth Factor Receptor (EGFR) Amplification Rates Observed in Screening Patients for Randomized Trials in Glioblastoma.” Journal of Neuro-Oncology, vol. 144, no. 1, Aug. 2019, pp. 205–10. EBSCOhost, https://doi.org/10.1007/s11060-019-03222-y.

APA

Lassman, A. B., Aldape, K. D., Ansell, P. J., Bain, E., Curran, W. J., Eoli, M., French, P. J., Kinoshita, M., Looman, J., Mehta, M., Muragaki, Y., Narita, Y., Ocampo, C., Roberts-Rapp, L., Song, M., Vogelbaum, M. A., Walenkamp, A. M. E., Wang, T. J. C., Zhang, P., & van den Bent, M. J. (2019). Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma. Journal of Neuro-Oncology, 144(1), 205–210. https://doi.org/10.1007/s11060-019-03222-y

Chicago

Lassman, Andrew B., Kenneth D. Aldape, Peter J. Ansell, Earle Bain, Walter J. Curran, Marica Eoli, Pim J. French, et al. 2019. “Epidermal Growth Factor Receptor (EGFR) Amplification Rates Observed in Screening Patients for Randomized Trials in Glioblastoma.” Journal of Neuro-Oncology 144 (1): 205–10. doi:10.1007/s11060-019-03222-y.